Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnoud H de Ru

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Cell Reports|June 13, 2025
Vault RNAs aid RNA virus infection by facilitating cytoplasmic localization of hnRNP C and ELAVL1Jorn E Stok, Sander B van der Kooij, Dennis Gravekamp, et al.
Molecular Therapy Oncolytics|November 3, 2023
Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.
The Journal of Clinical Investigation|January 15, 2019
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I van der Lee, Rogier M Reijmers, Maria W Honders, et al.
Blood|March 18, 2015
ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformationMir Farshid Alemdehy, Jurgen R Haanstra, Hans W J de Looper, et al.
Cancer Immunology Research|May 19, 2025
TCR-based therapy directed against kallikrein-related peptidase 4 is safe and effective against prostate cancerRosa A van Amerongen, Sander Tuit, Dennis F G Remst, et al.
Science Advances|April 10, 2026
Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoireHannes Kehm, Stefan Zens, Daniel Baumann, et al.
Frontiers in Immunology|April 7, 2023
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancerRosa A van Amerongen, Sander Tuit, Anne K Wouters, et al.
Leukemia|December 13, 2025
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemiaNadine E Struckman, Georgia Koutsoumpli, Rob C M de Jong, et al.
Blood|March 1, 2024
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigensKyra J Fuchs, Marian van de Meent, M Willy Honders, et al.
Cell Reports|November 9, 2025
Patient-derived organoids to study glycosylation dynamics during gastric diseaseLiliana Santos-Ferreira, Álvaro M Martins, Henrique O Duarte, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Cell Reports|June 13, 2025
Vault RNAs aid RNA virus infection by facilitating cytoplasmic localization of hnRNP C and ELAVL1Jorn E Stok, Sander B van der Kooij, Dennis Gravekamp, et al.
Molecular Therapy Oncolytics|November 3, 2023
Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapyMarije A J de Rooij, Dennis F G Remst, Dirk M van der Steen, et al.
The Journal of Clinical Investigation|January 15, 2019
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I van der Lee, Rogier M Reijmers, Maria W Honders, et al.
Blood|March 18, 2015
ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformationMir Farshid Alemdehy, Jurgen R Haanstra, Hans W J de Looper, et al.
Cancer Immunology Research|May 19, 2025
TCR-based therapy directed against kallikrein-related peptidase 4 is safe and effective against prostate cancerRosa A van Amerongen, Sander Tuit, Dennis F G Remst, et al.
Science Advances|April 10, 2026
Dissection of the T cell infiltrate in mouse pancreatic tumors reveals an extensive and diverse tumor-reactive T cell repertoireHannes Kehm, Stefan Zens, Daniel Baumann, et al.
Frontiers in Immunology|April 7, 2023
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancerRosa A van Amerongen, Sander Tuit, Anne K Wouters, et al.
Leukemia|December 13, 2025
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemiaNadine E Struckman, Georgia Koutsoumpli, Rob C M de Jong, et al.
Blood|March 1, 2024
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigensKyra J Fuchs, Marian van de Meent, M Willy Honders, et al.
Cell Reports|November 9, 2025
Patient-derived organoids to study glycosylation dynamics during gastric diseaseLiliana Santos-Ferreira, Álvaro M Martins, Henrique O Duarte, et al.
Pageof 10